IRIS Accounts Production v23.2.0.158 10057956 Board of Directors 1.4.22 31.3.23 31.3.23 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh100579562022-03-31100579562023-03-31100579562022-04-012023-03-31100579562021-03-31100579562021-04-012022-03-31100579562022-03-3110057956ns10:Originalns15:EnglandWales2022-04-012023-03-3110057956ns14:PoundSterlingns10:Original2022-04-012023-03-3110057956ns10:Originalns10:Director12022-04-012023-03-3110057956ns10:Original2022-04-012023-03-3110057956ns10:Original2023-03-3110057956ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3110057956ns10:Originalns10:SmallEntities2022-04-012023-03-3110057956ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3110057956ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3110057956ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3110057956ns10:Originalns10:FullAccounts2022-04-012023-03-3110057956ns10:Original2021-04-012022-03-3110057956ns10:Originalns10:Director22022-04-012023-03-3110057956ns10:Originalns10:RegisteredOffice2022-04-012023-03-3110057956ns10:Original2022-03-3110057956ns10:Originalns5:CurrentFinancialInstruments2023-03-3110057956ns10:Originalns5:CurrentFinancialInstruments2022-03-3110057956ns5:ShareCapitalns10:Original2023-03-3110057956ns5:ShareCapitalns10:Original2022-03-3110057956ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3110057956ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3110057956ns10:Originalns5:PlantMachinery2022-04-012023-03-3110057956ns10:Originalns5:PlantMachinery2022-03-3110057956ns10:Originalns5:PlantMachinery2023-03-3110057956ns10:Originalns5:PlantMachinery2022-03-3110057956ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3110057956ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-3110057956ns10:Original1ns10:Director12022-03-3110057956ns10:Original1ns10:Director12021-03-3110057956ns10:Original1ns10:Director12022-04-012023-03-3110057956ns10:Original1ns10:Director12021-04-012022-03-3110057956ns10:Original1ns10:Director12023-03-3110057956ns10:Original1ns10:Director12022-03-3110057956ns10:Originalns10:Director222022-03-3110057956ns10:Originalns10:Director222021-03-3110057956ns10:Originalns10:Director222022-04-012023-03-3110057956ns10:Originalns10:Director222021-04-012022-03-3110057956ns10:Originalns10:Director222023-03-3110057956ns10:Originalns10:Director222022-03-31
REGISTERED NUMBER: 10057956 (England and Wales)













Unaudited Financial Statements

for the Year Ended 31 March 2023

for

MEL ANAESTHETIC SERVICES LTD

MEL ANAESTHETIC SERVICES LTD (REGISTERED NUMBER: 10057956)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


MEL ANAESTHETIC SERVICES LTD

Company Information
for the Year Ended 31 March 2023







DIRECTORS: Dr M E Ladlow
Dr N L Mather





REGISTERED OFFICE: 20 Duchy Road
Harrogate
North Yorkshire
HG1 2ER





REGISTERED NUMBER: 10057956 (England and Wales)





ACCOUNTANTS: BK Plus Ltd
52 St Johns Lane
Halifax
West Yorkshire
HX1 2BW

MEL ANAESTHETIC SERVICES LTD (REGISTERED NUMBER: 10057956)

Balance Sheet
31 March 2023

31.3.23 31.3.22
Notes £    £    £    £   
FIXED ASSETS
Property, plant and equipment 4 4,472 2,645

CURRENT ASSETS
Debtors 5 87,883 159,930
Investments 6 171,042 44,163
Cash at bank and in hand 13,599 9,353
272,524 213,446
CREDITORS
Amounts falling due within one year 7 34,158 25,890
NET CURRENT ASSETS 238,366 187,556
TOTAL ASSETS LESS CURRENT LIABILITIES 242,838 190,201

PROVISIONS FOR LIABILITIES 879 914
NET ASSETS 241,959 189,287

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 241,859 189,187
241,959 189,287

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MEL ANAESTHETIC SERVICES LTD (REGISTERED NUMBER: 10057956)

Balance Sheet - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22 November 2023 and were signed on its behalf by:





Dr M E Ladlow - Director


MEL ANAESTHETIC SERVICES LTD (REGISTERED NUMBER: 10057956)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

MEL Anaesthetic Services Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33.33% on cost and Straight line over 4 years

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - NIL).

MEL ANAESTHETIC SERVICES LTD (REGISTERED NUMBER: 10057956)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

4. PROPERTY, PLANT AND EQUIPMENT
Plant and
machinery
etc
£   
COST
At 1 April 2022 10,659
Additions 5,093
Disposals (829 )
At 31 March 2023 14,923
DEPRECIATION
At 1 April 2022 8,014
Charge for year 3,266
Eliminated on disposal (829 )
At 31 March 2023 10,451
NET BOOK VALUE
At 31 March 2023 4,472
At 31 March 2022 2,645

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Trade debtors 16,084 13,649
Other debtors 71,799 146,281
87,883 159,930

6. CURRENT ASSET INVESTMENTS
31.3.23 31.3.22
£    £   
Listed investments 171,042 44,163

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Taxation and social security 30,586 21,863
Other creditors 3,572 4,027
34,158 25,890

MEL ANAESTHETIC SERVICES LTD (REGISTERED NUMBER: 10057956)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2023 and 31 March 2022:

31.3.23 31.3.22
£    £   
Dr M E Ladlow
Balance outstanding at start of year 87,940 19,113
Amounts advanced 46,390 76,073
Amounts repaid (90,644 ) (7,246 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 43,686 87,940

Dr N L Mather
Balance outstanding at start of year 49,205 8,999
Amounts advanced 10,134 40,206
Amounts repaid (49,205 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 10,134 49,205